Quel est le prix pour 3D Global Biotech Inc. (6808)

Le prix pour 3D Global Biotech Inc. (6808) est $1.16

Quelle est la capitalisation boursière pour 3D Global Biotech Inc. (6808)

La capitalisation boursière pour 3D Global Biotech Inc. (6808) est $89.35M

Revenus de 3D Global Biotech Inc. (6808)

Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in the development of advanced medical materials designed for human body reconstruction. The company leverages sophisticated cell culture systems, cutting-edge 3D printing technology, and proprietary bio-inks hydrogel to create personalized, patient-specific cell-based medical products. Beyond product manufacturing, 3DGBI is dedicated to building platforms for human tissue and organ regeneration, engineering customized medical equipment, and undertaking significant professional research. Its extensive product range includes artificial bone substitutes, skull fixation systems, biological dressings, bio-inks, and bioprinting machinery. They also offer specialized solutions for orthopedic, dental, cranial, and scalp reconstruction. The company serves a broad spectrum of clients, including medical centers, research institutions, businesses, and distributors. 3DGBI actively fosters an interdisciplinary alliance, bringing together expertise from industry, government, academia, research, and medicine. It was established in 2014.

Année	Revenus	Changez
Pas assez de données pour les dates fournies.

Année

Revenus

Changez

Pas assez de données pour les dates fournies.

Entreprise	Revenus	Différence de revenus	Pays
Vertex Pharmaceuticals Incorporated VRTX.US	$12.62B	-	US
Argenx SE ARGX.US	$6.02B	-	NL
Moderna, Inc. MRNA.US	$2.23B	-	US
CSL Limited CSL.AX	$15.74B	-	AU
Lonza Group AG LONN.SW	-	-	CH

Entreprise

Revenus

Différence de revenus

Pays